Research Article

Evaluation of Antioxidant Ability In Vitro and Bioavailability of trans-Cinnamic Acid Nanoparticle by Liquid Antisolvent Precipitate

Table 2

The pharmacokinetic parameters of TCD by oral administration ().

Raw TCDTCD nanoparticles

(1/h)0.99 ± 0.0071.03 ± 0.013
(1/h)0.01 ± 0.000.01 ± 0.00
(h)0.70 ± 0.0040.67 ± 0.009
(h)0.08 ± 0.0020.08 ± 0.002
(mg/L)0.65 ± 0.031.26 ± 0.06
(mg/Lh)1.32 ± 0.042.85 ± 0.08
(mg/Lh)10.13 ± 0.4713.62 ± 0.67
(h)7.62 ± 0.224.78 ± 0.15

The elimination rate constant.
The absorption rate constant.
The elimination half-life.
Time of peak concentration.
Peak of maximum concentration.
Area under the concentration-time profile curve until last observation.
Area under moment curve computed to the last observation.
Mean residence time.